_id

695fb993c2e91020a7bd42de

Ticker

0J2O.LSE

Name

Halozyme Therapeutics, Inc.

Exchange

LSE

Address

12390 El Camino Real, San Diego, CA, United States, 92130

Country

UK

Sector

Industry

Currency

USD

Website

https://halozyme.com

Description

Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally. The company's products are based on the patented recombinant human hyaluronidase enzyme (rHuPH20) that enables delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. It offers Hylenex recombinant, a formulation of rHuPH20 that facilitates subcutaneous (SC) administration to enhance the dispersion and absorption of other injected drugs in SC urography and to enhance resorption of radiopaque agents; XYOSTED, an injection for SC administration of testosterone replacement therapy; and ATRS-1902, a proprietary drug device combination product. The company offers Herceptin (trastuzumab), Herceptin Hylecta, and Phesgo to treat breast cancer; Mabthera SC for chronic lymphocytic leukemia treatment; HYQVIA to treat primary immunodeficiency disorders; Ocrevus (ocrelizumab) for multiple sclerosis; N6LS and cabotegravir to treat HIV; DARZALEX to treat amyloidosis, and smoldering and multiple myeloma; Epinephrine Injection to treat allergic reactions; nivolumab and relatlimab to treat solid tumors; teriparatide injections; OTREXUP, an SC methotrexate injection for severe active rheumatoid arthritis, severe recalcitrant psoriasis, and active polyarticular juvenile idiopathic arthritis; ARGX-113; and ARGX-117 to treat severe autoimmune diseases in multifocal motor neuropathy. The company has collaborations and licensing agreements with F. Hoffmann-La Roche, Ltd. and Hoffmann-La Roche, Inc.; Takeda Pharmaceuticals International AG and Baxalta US Inc; Pfizer Inc.; Janssen Biotech, Inc.; AbbVie, Inc.; Eli Lilly and Company; Bristol Myers Squibb Company; argenx BVBA; ViiV Healthcare; Chugai Pharmaceutical Co., Ltd.; and Acumen Pharmaceuticals, Inc. The company was founded in 1998 and is headquartered in San Diego, California.

Last Close

75.41

Volume

195

Current Price

75

Change

0.27

Last Updated

2026-01-08T14:05:06.937Z

Ipo Date

-

Market Cap

1173671731200

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Current Quarter

2025-09-30

Revenue

354264000

Cost Of Revenue

55242000

Gross Profit

299022000

Operating Expenses

81101000

Operating Income

217921000

Interest Expense

4296000

Pretax Income

218958000

Net Income

175225000

Eps

1.4323842689097612

Dividends Per Share

-

Shares Outstanding

143948992

Income Tax Expense

43733000

EBITDA

284625000

Operating Margin

61.51372987376645

Total Other Income Expense Net

1037000

Cash

419665000

Short Term Investments

282298000

Receivables

346035000

Inventories

185796000

Total Current Assets

1328749000

Property Plant Equipment

71420000

Total Assets

2221232000

Payables

15360000

Short Term Debt

710685000

Long Term Debt

-

Total Liabilities

1717317000

Equity

503915000

Bs_currency_symbol

-

Depreciation

22278000

Change In Working Capital

-51116000

Cash From Operations

178597000

Capital Expenditures

3030000

Cash From Investing

201609000

Cash From Financing

-22402000

Net Change In Cash

357804000

Cf_currency_symbol

-

PE

0.2416

PB

18.20708849706796

ROE

34.772729527797345

ROA

7.888640178063346

FCF

175567000

Fcf Percent

0.49558239053361336

Piotroski FScore

4

Health Score

66

Deep Value Investing Score

6

Defensive Investing Score

6.5

Dividend Investing Score

3

Economic Moat Investing Score

10

Garp Investing Score

7

Growth Investing Score

5.5

Momentum Investing Score

4

Net Net Investing Score

2.5

Quality Investing Score

9

Value Investing Score

7

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

354264000

Quarters > 0 > income Statement > cost Of Revenue

55242000

Quarters > 0 > income Statement > gross Profit

299022000

Quarters > 0 > income Statement > operating Expenses

81101000

Quarters > 0 > income Statement > operating Income

217921000

Quarters > 0 > income Statement > interest Expense

4296000

Quarters > 0 > income Statement > pretax Income

218958000

Quarters > 0 > income Statement > net Income

175225000

Quarters > 0 > income Statement > eps

1.4323842689097612

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

122331000

Quarters > 0 > income Statement > income Tax Expense

43733000

Quarters > 0 > income Statement > EBITDA

284625000

Quarters > 0 > income Statement > operating Margin

61.51372987376645

Quarters > 0 > income Statement > total Other Income Expense Net

1037000

Quarters > 0 > income Statement > currency_symbol

-

Quarters > 0 > balance Sheet > cash

419665000

Quarters > 0 > balance Sheet > short Term Investments

282298000

Quarters > 0 > balance Sheet > receivables

346035000

Quarters > 0 > balance Sheet > inventories

185796000

Quarters > 0 > balance Sheet > total Current Assets

1328749000

Quarters > 0 > balance Sheet > property Plant Equipment

71420000

Quarters > 0 > balance Sheet > total Assets

2221232000

Quarters > 0 > balance Sheet > payables

15360000

Quarters > 0 > balance Sheet > short Term Debt

710685000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

1717317000

Quarters > 0 > balance Sheet > equity

503915000

Quarters > 0 > balance Sheet > currency_symbol

-

Quarters > 0 > cash Flow > net Income

175225000

Quarters > 0 > cash Flow > depreciation

22278000

Quarters > 0 > cash Flow > change In Working Capital

-51116000

Quarters > 0 > cash Flow > cash From Operations

178597000

Quarters > 0 > cash Flow > capital Expenditures

3030000

Quarters > 0 > cash Flow > cash From Investing

201609000

Quarters > 0 > cash Flow > cash From Financing

-22402000

Quarters > 0 > cash Flow > net Change In Cash

357804000

Quarters > 0 > cash Flow > currency_symbol

-

Quarters > 0 > ratios > PE

1.4323842689097612

Quarters > 0 > ratios > PB

18.20708849706796

Quarters > 0 > ratios > ROE

34.772729527797345

Quarters > 0 > ratios > ROA

7.888640178063346

Quarters > 0 > ratios > FCF

175567000

Quarters > 0 > ratios > Piotroski FScore

4

Quarters > 0 > ratios > fcf Percent

0.49558239053361336

Quarters > 0 > health Score

66

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

325719000

Quarters > 1 > income Statement > cost Of Revenue

46359000

Quarters > 1 > income Statement > gross Profit

279360000

Quarters > 1 > income Statement > operating Expenses

76919000

Quarters > 1 > income Statement > operating Income

202441000

Quarters > 1 > income Statement > interest Expense

4394000

Quarters > 1 > income Statement > pretax Income

204938000

Quarters > 1 > income Statement > net Income

165160000

Quarters > 1 > income Statement > eps

1.3302405000080542

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

124158000

Quarters > 1 > income Statement > income Tax Expense

39778000

Quarters > 1 > income Statement > EBITDA

229834000

Quarters > 1 > income Statement > operating Margin

62.1520390275053

Quarters > 1 > income Statement > total Other Income Expense Net

2497000

Quarters > 1 > income Statement > currency_symbol

-

Quarters > 1 > balance Sheet > cash

61861000

Quarters > 1 > balance Sheet > short Term Investments

486316000

Quarters > 1 > balance Sheet > receivables

316339000

Quarters > 1 > balance Sheet > inventories

181505000

Quarters > 1 > balance Sheet > total Current Assets

1122673000

Quarters > 1 > balance Sheet > property Plant Equipment

71520000

Quarters > 1 > balance Sheet > total Assets

2053899000

Quarters > 1 > balance Sheet > payables

18691000

Quarters > 1 > balance Sheet > short Term Debt

-

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

1721151000

Quarters > 1 > balance Sheet > equity

332748000

Quarters > 1 > balance Sheet > currency_symbol

-

Quarters > 1 > cash Flow > net Income

165160000

Quarters > 1 > cash Flow > depreciation

22354000

Quarters > 1 > cash Flow > change In Working Capital

-62326000

Quarters > 1 > cash Flow > cash From Operations

99711000

Quarters > 1 > cash Flow > capital Expenditures

1563000

Quarters > 1 > cash Flow > cash From Investing

84788000

Quarters > 1 > cash Flow > cash From Financing

-298966000

Quarters > 1 > cash Flow > net Change In Cash

-114467000

Quarters > 1 > cash Flow > currency_symbol

USD

Quarters > 1 > ratios > PE

1.3302405000080542

Quarters > 1 > ratios > PB

27.98469111760251

Quarters > 1 > ratios > ROE

49.63515933980069

Quarters > 1 > ratios > ROA

8.04129122220713

Quarters > 1 > ratios > FCF

98148000

Quarters > 1 > ratios > Piotroski FScore

3

Quarters > 1 > ratios > fcf Percent

0.30132721763237635

Quarters > 1 > health Score

65

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

264861000

Quarters > 2 > income Statement > cost Of Revenue

48403000

Quarters > 2 > income Statement > gross Profit

216458000

Quarters > 2 > income Statement > operating Expenses

74923000

Quarters > 2 > income Statement > operating Income

141535000

Quarters > 2 > income Statement > interest Expense

4525000

Quarters > 2 > income Statement > pretax Income

143828000

Quarters > 2 > income Statement > net Income

118095000

Quarters > 2 > income Statement > eps

0.9324958150405862

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

126644000

Quarters > 2 > income Statement > income Tax Expense

25733000

Quarters > 2 > income Statement > EBITDA

168802000

Quarters > 2 > income Statement > operating Margin

53.43746342421119

Quarters > 2 > income Statement > total Other Income Expense Net

2293000

Quarters > 2 > income Statement > currency_symbol

-

Quarters > 2 > balance Sheet > cash

176328000

Quarters > 2 > balance Sheet > short Term Investments

571594000

Quarters > 2 > balance Sheet > receivables

304621000

Quarters > 2 > balance Sheet > inventories

164868000

Quarters > 2 > balance Sheet > total Current Assets

1262028000

Quarters > 2 > balance Sheet > property Plant Equipment

72816000

Quarters > 2 > balance Sheet > total Assets

2196532000

Quarters > 2 > balance Sheet > payables

20074000

Quarters > 2 > balance Sheet > short Term Debt

-

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

1714262000

Quarters > 2 > balance Sheet > equity

482270000

Quarters > 2 > balance Sheet > currency_symbol

-

Quarters > 2 > cash Flow > net Income

118095000

Quarters > 2 > cash Flow > depreciation

20449000

Quarters > 2 > cash Flow > change In Working Capital

7472000

Quarters > 2 > cash Flow > cash From Operations

154221000

Quarters > 2 > cash Flow > capital Expenditures

950000

Quarters > 2 > cash Flow > cash From Investing

-90422000

Quarters > 2 > cash Flow > cash From Financing

-3321000

Quarters > 2 > cash Flow > net Change In Cash

60478000

Quarters > 2 > cash Flow > currency_symbol

USD

Quarters > 2 > ratios > PE

0.9324958150405862

Quarters > 2 > ratios > PB

19.69498413751633

Quarters > 2 > ratios > ROE

24.48732038069961

Quarters > 2 > ratios > ROA

5.376429753811919

Quarters > 2 > ratios > FCF

153271000

Quarters > 2 > ratios > Piotroski FScore

4

Quarters > 2 > ratios > fcf Percent

0.5786846685620004

Quarters > 2 > health Score

64

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

298008000

Quarters > 3 > income Statement > cost Of Revenue

42055000

Quarters > 3 > income Statement > gross Profit

255953000

Quarters > 3 > income Statement > operating Expenses

80452000

Quarters > 3 > income Statement > operating Income

175501000

Quarters > 3 > income Statement > interest Expense

4540000

Quarters > 3 > income Statement > pretax Income

178214000

Quarters > 3 > income Statement > net Income

137012000

Quarters > 3 > income Statement > eps

1.058629002348869

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

129424000

Quarters > 3 > income Statement > income Tax Expense

41202000

Quarters > 3 > income Statement > EBITDA

203169000

Quarters > 3 > income Statement > operating Margin

58.89137204370353

Quarters > 3 > income Statement > total Other Income Expense Net

2713000

Quarters > 3 > income Statement > currency_symbol

-

Quarters > 3 > balance Sheet > cash

115850000

Quarters > 3 > balance Sheet > short Term Investments

480224000

Quarters > 3 > balance Sheet > receivables

308455000

Quarters > 3 > balance Sheet > inventories

141860000

Quarters > 3 > balance Sheet > total Current Assets

1085340000

Quarters > 3 > balance Sheet > property Plant Equipment

75035000

Quarters > 3 > balance Sheet > total Assets

2063477000

Quarters > 3 > balance Sheet > payables

10249000

Quarters > 3 > balance Sheet > short Term Debt

-

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

1699656000

Quarters > 3 > balance Sheet > equity

363821000

Quarters > 3 > balance Sheet > currency_symbol

-

Quarters > 3 > cash Flow > net Income

137012000

Quarters > 3 > cash Flow > depreciation

22259000

Quarters > 3 > cash Flow > change In Working Capital

-24817000

Quarters > 3 > cash Flow > cash From Operations

178467000

Quarters > 3 > cash Flow > capital Expenditures

3052000

Quarters > 3 > cash Flow > cash From Investing

29480000

Quarters > 3 > cash Flow > cash From Financing

-246415000

Quarters > 3 > cash Flow > net Change In Cash

-38468000

Quarters > 3 > cash Flow > currency_symbol

USD

Quarters > 3 > ratios > PE

1.058629002348869

Quarters > 3 > ratios > PB

26.68015315223695

Quarters > 3 > ratios > ROE

37.659178552090175

Quarters > 3 > ratios > ROA

6.639860778675992

Quarters > 3 > ratios > FCF

175415000

Quarters > 3 > ratios > Piotroski FScore

4

Quarters > 3 > ratios > fcf Percent

0.5886251375801992

Quarters > 3 > health Score

65

Annuals > 0 > quarter

2024-12-31

Annuals > 0 > income Statement > revenue

1015324000

Annuals > 0 > income Statement > cost Of Revenue

159417000

Annuals > 0 > income Statement > gross Profit

855907000

Annuals > 0 > income Statement > operating Expenses

304432000

Annuals > 0 > income Statement > operating Income

551475000

Annuals > 0 > income Statement > interest Expense

18095000

Annuals > 0 > income Statement > pretax Income

557132000

Annuals > 0 > income Statement > net Income

444091000

Annuals > 0 > income Statement > eps

3.4312878600568673

Annuals > 0 > income Statement > dividends Per Share

-

Annuals > 0 > income Statement > shares Outstanding

129424000

Annuals > 0 > income Statement > income Tax Expense

113041000

Annuals > 0 > income Statement > EBITDA

656539000

Annuals > 0 > income Statement > operating Margin

54.31517426949427

Annuals > 0 > income Statement > total Other Income Expense Net

5657000

Annuals > 0 > income Statement > currency_symbol

-

Annuals > 0 > balance Sheet > cash

115850000

Annuals > 0 > balance Sheet > short Term Investments

480224000

Annuals > 0 > balance Sheet > receivables

308455000

Annuals > 0 > balance Sheet > inventories

141860000

Annuals > 0 > balance Sheet > total Current Assets

1085340000

Annuals > 0 > balance Sheet > property Plant Equipment

75035000

Annuals > 0 > balance Sheet > total Assets

2063477000

Annuals > 0 > balance Sheet > payables

10249000

Annuals > 0 > balance Sheet > short Term Debt

-

Annuals > 0 > balance Sheet > long Term Debt

-

Annuals > 0 > balance Sheet > total Liabilities

1699656000

Annuals > 0 > balance Sheet > equity

363821000

Annuals > 0 > balance Sheet > currency_symbol

-

Annuals > 0 > cash Flow > net Income

444091000

Annuals > 0 > cash Flow > depreciation

88662000

Annuals > 0 > cash Flow > change In Working Capital

-136270000

Annuals > 0 > cash Flow > cash From Operations

479064000

Annuals > 0 > cash Flow > capital Expenditures

10696000

Annuals > 0 > cash Flow > cash From Investing

-262723000

Annuals > 0 > cash Flow > cash From Financing

-218861000

Annuals > 0 > cash Flow > net Change In Cash

-2520000

Annuals > 0 > cash Flow > currency_symbol

-

Annuals > 0 > ratios > PE

3.4312878600568673

Annuals > 0 > ratios > PB

26.68015315223695

Annuals > 0 > ratios > ROE

122.06304748763814

Annuals > 0 > ratios > ROA

21.52149018380142

Annuals > 0 > ratios > FCF

468368000

Annuals > 0 > ratios > Piotroski FScore

4

Annuals > 0 > ratios > fcf Percent

0.4612990533071217

Annuals > 0 > health Score

68

Annuals > 1 > quarter

2023-12-31

Annuals > 1 > income Statement > revenue

829253000

Annuals > 1 > income Statement > cost Of Revenue

192361000

Annuals > 1 > income Statement > gross Profit

636892000

Annuals > 1 > income Statement > operating Expenses

299318000

Annuals > 1 > income Statement > operating Income

337574000

Annuals > 1 > income Statement > interest Expense

18762000

Annuals > 1 > income Statement > pretax Income

348329000

Annuals > 1 > income Statement > net Income

281594000

Annuals > 1 > income Statement > eps

2.0983628546092685

Annuals > 1 > income Statement > dividends Per Share

-

Annuals > 1 > income Statement > shares Outstanding

134197000

Annuals > 1 > income Statement > income Tax Expense

66735000

Annuals > 1 > income Statement > EBITDA

451947000

Annuals > 1 > income Statement > operating Margin

40.70820364834375

Annuals > 1 > income Statement > total Other Income Expense Net

10755000

Annuals > 1 > income Statement > currency_symbol

-

Annuals > 1 > balance Sheet > cash

118370000

Annuals > 1 > balance Sheet > short Term Investments

217630000

Annuals > 1 > balance Sheet > receivables

234210000

Annuals > 1 > balance Sheet > inventories

127601000

Annuals > 1 > balance Sheet > total Current Assets

746424000

Annuals > 1 > balance Sheet > property Plant Equipment

74944000

Annuals > 1 > balance Sheet > total Assets

1733270000

Annuals > 1 > balance Sheet > payables

11816000

Annuals > 1 > balance Sheet > short Term Debt

-

Annuals > 1 > balance Sheet > long Term Debt

-

Annuals > 1 > balance Sheet > total Liabilities

1649462000

Annuals > 1 > balance Sheet > equity

83808000

Annuals > 1 > balance Sheet > currency_symbol

-

Annuals > 1 > cash Flow > net Income

281594000

Annuals > 1 > cash Flow > depreciation

84856000

Annuals > 1 > cash Flow > change In Working Capital

-38671000

Annuals > 1 > cash Flow > cash From Operations

388571000

Annuals > 1 > cash Flow > capital Expenditures

15294000

Annuals > 1 > cash Flow > cash From Investing

-96909000

Annuals > 1 > cash Flow > cash From Financing

-407987000

Annuals > 1 > cash Flow > net Change In Cash

-116325000

Annuals > 1 > cash Flow > currency_symbol

USD

Annuals > 1 > ratios > PE

2.0983628546092685

Annuals > 1 > ratios > PB

120.09324885452462

Annuals > 1 > ratios > ROE

335.9989499809088

Annuals > 1 > ratios > ROA

16.246401310817127

Annuals > 1 > ratios > FCF

373277000

Annuals > 1 > ratios > Piotroski FScore

4

Annuals > 1 > ratios > fcf Percent

0.4501364481044989

Annuals > 1 > health Score

68

Annuals > 2 > quarter

2022-12-31

Annuals > 2 > income Statement > revenue

660116000

Annuals > 2 > income Statement > cost Of Revenue

139304000

Annuals > 2 > income Statement > gross Profit

520812000

Annuals > 2 > income Statement > operating Expenses

253281000

Annuals > 2 > income Statement > operating Income

267531000

Annuals > 2 > income Statement > interest Expense

16947000

Annuals > 2 > income Statement > pretax Income

248918000

Annuals > 2 > income Statement > net Income

202129000

Annuals > 2 > income Statement > eps

1.437535559854347

Annuals > 2 > income Statement > dividends Per Share

-

Annuals > 2 > income Statement > shares Outstanding

140608000

Annuals > 2 > income Statement > income Tax Expense

46789000

Annuals > 2 > income Statement > EBITDA

315506000

Annuals > 2 > income Statement > operating Margin

40.52787691860218

Annuals > 2 > income Statement > total Other Income Expense Net

-18613000

Annuals > 2 > income Statement > currency_symbol

-

Annuals > 2 > balance Sheet > cash

234195000

Annuals > 2 > balance Sheet > short Term Investments

128599000

Annuals > 2 > balance Sheet > receivables

231072000

Annuals > 2 > balance Sheet > inventories

100123000

Annuals > 2 > balance Sheet > total Current Assets

739013000

Annuals > 2 > balance Sheet > property Plant Equipment

75570000

Annuals > 2 > balance Sheet > total Assets

1841511000

Annuals > 2 > balance Sheet > payables

17693000

Annuals > 2 > balance Sheet > short Term Debt

13334000

Annuals > 2 > balance Sheet > long Term Debt

-

Annuals > 2 > balance Sheet > total Liabilities

1671713000

Annuals > 2 > balance Sheet > equity

169798000

Annuals > 2 > balance Sheet > currency_symbol

-

Annuals > 2 > cash Flow > net Income

202129000

Annuals > 2 > cash Flow > depreciation

57480000

Annuals > 2 > cash Flow > change In Working Capital

-110486000

Annuals > 2 > cash Flow > cash From Operations

240110000

Annuals > 2 > cash Flow > capital Expenditures

4810000

Annuals > 2 > cash Flow > cash From Investing

-487005000

Annuals > 2 > cash Flow > cash From Financing

362371000

Annuals > 2 > cash Flow > net Change In Cash

115476000

Annuals > 2 > cash Flow > currency_symbol

USD

Annuals > 2 > ratios > PE

1.437535559854347

Annuals > 2 > ratios > PB

62.10673859527203

Annuals > 2 > ratios > ROE

119.04086031637593

Annuals > 2 > ratios > ROA

10.97625808371495

Annuals > 2 > ratios > FCF

235300000

Annuals > 2 > ratios > Piotroski FScore

4

Annuals > 2 > ratios > fcf Percent

0.35645250228747677

Annuals > 2 > health Score

68

Annuals > 3 > quarter

2021-12-31

Annuals > 3 > income Statement > revenue

443310000

Annuals > 3 > income Statement > cost Of Revenue

81413000

Annuals > 3 > income Statement > gross Profit

361897000

Annuals > 3 > income Statement > operating Expenses

85995000

Annuals > 3 > income Statement > operating Income

275902000

Annuals > 3 > income Statement > interest Expense

7526000

Annuals > 3 > income Statement > pretax Income

248518000

Annuals > 3 > income Statement > net Income

402710000

Annuals > 3 > income Statement > eps

2.7433308809504346

Annuals > 3 > income Statement > dividends Per Share

-

Annuals > 3 > income Statement > shares Outstanding

146796000

Annuals > 3 > income Statement > income Tax Expense

-154192000

Annuals > 3 > income Statement > EBITDA

259041000

Annuals > 3 > income Statement > operating Margin

62.23680945613679

Annuals > 3 > income Statement > total Other Income Expense Net

-27384000

Annuals > 3 > income Statement > currency_symbol

-

Annuals > 3 > balance Sheet > cash

118719000

Annuals > 3 > balance Sheet > short Term Investments

622203000

Annuals > 3 > balance Sheet > receivables

90975000

Annuals > 3 > balance Sheet > inventories

53908000

Annuals > 3 > balance Sheet > total Current Assets

926287000

Annuals > 3 > balance Sheet > property Plant Equipment

8794000

Annuals > 3 > balance Sheet > total Assets

1104429000

Annuals > 3 > balance Sheet > payables

1541000

Annuals > 3 > balance Sheet > short Term Debt

89419000

Annuals > 3 > balance Sheet > long Term Debt

-

Annuals > 3 > balance Sheet > total Liabilities

907476000

Annuals > 3 > balance Sheet > equity

196953000

Annuals > 3 > balance Sheet > currency_symbol

-

Annuals > 3 > cash Flow > net Income

402710000

Annuals > 3 > cash Flow > depreciation

6639000

Annuals > 3 > cash Flow > change In Working Capital

2571000

Annuals > 3 > cash Flow > cash From Operations

299440000

Annuals > 3 > cash Flow > capital Expenditures

1457000

Annuals > 3 > cash Flow > cash From Investing

-406289000

Annuals > 3 > cash Flow > cash From Financing

77865000

Annuals > 3 > cash Flow > net Change In Cash

-28984000

Annuals > 3 > cash Flow > currency_symbol

USD

Annuals > 3 > ratios > PE

2.7433308809504346

Annuals > 3 > ratios > PB

55.900138611750016

Annuals > 3 > ratios > ROE

204.47010200403142

Annuals > 3 > ratios > ROA

36.463185954008814

Annuals > 3 > ratios > FCF

297983000

Annuals > 3 > ratios > Piotroski FScore

3

Annuals > 3 > ratios > fcf Percent

0.6721774830254224

Annuals > 3 > health Score

67

Valuation > metrics > PE

0.2416

Valuation > metrics > PB

18.20708849706796

Valuation > final Score

40

Valuation > verdict

204.7% Overvalued

Profitability > metrics > ROE

34.772729527797345

Profitability > metrics > ROA

13.187215945223665

Profitability > metrics > Net Margin

0.49461700878440934

Profitability > final Score

100

Profitability > verdict

Adequate

Risk > metrics > Debt Equity

3.407949753430638

Risk > metrics > Interest Coverage

50.72648975791434

Risk > final Score

46

Risk > verdict

High

Liquidity > metrics > Current Ratio

1.830119345219649

Liquidity > metrics > Quick Ratio

1.5742178515105814

Liquidity > final Score

96

Liquidity > verdict

Great

Prev Valuations > 0

40

Prev Valuations > 1

40

Prev Valuations > 2

40

Prev Profitabilities > 0

100

Prev Profitabilities > 1

98

Prev Profitabilities > 2

100

Prev Risks > 0

46

Prev Risks > 1

46

Prev Risks > 2

46

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2026-01-20T23:13:39.108Z

Earnings History > 0 > period

2025-12-31

Earnings History > 0 > report Date

2026-02-17

Earnings History > 0 > date

2025-12-31

Earnings History > 0 > before After Market

AfterMarket

Earnings History > 0 > currency

-

Earnings History > 0 > eps Actual

-

Earnings History > 0 > eps Estimate

1.91

Earnings History > 0 > eps Difference

0

Earnings History > 0 > surprise Percent

-